Cargando…
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
Hepatocellular cellular carcinoma (HCC) is one of the most challenging liver cancer subtypes. Due to lack of cell surface biomarkers and highly metastatic nature, early detection and targeted therapy of HCC is an unmet need. Galactosamine (Gal) is among the few selective ligands used for targeting H...
Autores principales: | Yousef, Shaimaa, Alsaab, Hashem O., Sau, Samaresh, Iyer, Arun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305692/ https://www.ncbi.nlm.nih.gov/pubmed/30603704 http://dx.doi.org/10.1016/j.heliyon.2018.e01071 |
Ejemplares similares
-
Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma
por: Alsaab, Hashem, et al.
Publicado: (2017) -
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019) -
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017) -
PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer
por: Sau, Samaresh, et al.
Publicado: (2019) -
Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)